The Methylation Genomics panel is an innovative assessment designed to offer insight into the methylation pathway, also known as 1-carbon metabolism. By investigating genetic predispositions for altered enzymatic activity, this profile can help clinicians design more targeted treatment strategies to optimize patient outcomes. This test is not available for patients under 2 years old.